Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Pediatr Pulmonol. 2024 Sep;59 Suppl 1:S115-S122. doi: 10.1002/ppul.27174.
Up to 90% of people with CF (pwCF) will have some form of hepatobiliary involvement. This manuscript aims to explore the different endovascular, endoscopic, radiological and surgical procedures available to diagnose and manage the most severe form of CF hepatobiliary involvement (CFHBI) known as advanced cystic fibrosis liver disease (aCFLD), seen in 10% of pwCF. These procedures and interventions include liver biopsy, hepatic venous pressure gradient measurement, gastrostomy tube placement to optimize nutrition, paracentesis, endoscopic variceal control of bleeding and portosystemic shunting before liver transplantation. By utilizing advanced diagnostic or surgical techniques, healthcare professionals of pwCF can more effectively manage patients with CFHBI and aCFLD and potentially improve patient outcomes.
高达 90%的囊性纤维化(CF)患者(pwCF)将有某种形式的肝胆受累。本文旨在探讨可用于诊断和治疗最严重形式的 CF 肝胆受累(CFHBI)的不同血管内、内镜、放射和手术程序,这种最严重形式的 CFHBI 被称为先进的囊性纤维化肝病(aCFLD),在 10%的 pwCF 中可见。这些程序和干预措施包括肝活检、肝静脉压力梯度测量、胃造口管放置以优化营养、经皮穿刺引流、内镜静脉曲张出血控制和肝移植前的门体分流。通过使用先进的诊断或手术技术,pwCF 的医疗保健专业人员可以更有效地管理 CFHBI 和 aCFLD 患者,并有可能改善患者的预后。